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Background: Dried blood (Guthrie card) spots provide an efficient way to collect and store blood specimens. DNA
from this source has been utilised for a number of molecular analyses including genome-wide association studies,
but only few studies have tested the feasibility of using it for epigenetic applications, particularly at a genome-wide
level.
Results: In this study, we demonstrate the successful use of DNA isolated from archived dried blood spots for the
Infinium HumanMethylation450 Beadchip, along with DNA from matched frozen buffy coats. We obtained high
quality and reproducible genome-wide DNA methylation profiles using both sample types. We also report high
correlations (r > 0.9907) between DNA obtained from matched dried blood spots and frozen buffy coats, sufficient
to distinguish between unrelated individuals.
Conclusions: We, thus, demonstrate that DNA from archived dried blood spots is suitable for genome-wide DNA
methylation profiling.
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Genome-wide DNA methylationBackground
Dried blood spots, or Guthrie Cards are obtained rou-
tinely from newborns in many developed countries to
screen for metabolic disorders [1]. These specimens also
provide a long-term, cost-effective and convenient alter-
native to freezing blood [2] and have been used by many
large epidemiological studies such as the Melbourne
Collaborative Cohort Study [3], the Breast Cancer Family
Registry [4] and the IARC Biobank (http://ibb.iarc.fr).
Given the size of these studies, the ability to use this
source of DNA with current genetic research platforms
will enable them to make a considerable contribution to
our understanding of the genetics of human disease. The
successful use of DNA from dried blood spots (involving
whole-genome amplification of the DNA to enhance
sensitivity) for downstream genome-wide applications* Correspondence: msouthey@unimelb.edu.au
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reproduction in any medium, provided the orsuch as microarray-based SNP genotyping has been oc-
casionally reported [5,6].
The significance of DNA methylation marks to human
health is an emerging field. For instance, aberrant DNA
methylation marks both loci-specific and globally are asso-
ciated with virtually all cancers [7]. Their significance has
led to the development of techniques enabling “epigenome-
wide” measures. Commonly employed methods include
MeDIP-seq (Methylated DNA ImmunoPrecipitation se-
quencing) and MBD-seq (Methyl-CpG Binding Domain
protein sequencing), which involve the enrichment of
methylated DNA using antibodies or methyl-binding do-
mains [8]. These methods rely on an efficient affinity be-
tween the molecules and, thus, require a large amount of
starting DNA and may be prone to potential biases. The
Infinium HumanMethylation450 (HM450) Beadchip ar-
ray (Illumina), the successor to the HM27, enables the
detection of DNA methylation levels at 486,685 CpG dinu-
cleotides across the genome and is one of the most com-
prehensive microarray methods to date for investigating the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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be highly reproducible [10] and to require a relatively small
amount of DNA (as low as 500 ng) making the utility of
limited DNA available from dried blood spots feasible. Like
many other DNA methylation assays, this platform is based
on sodium bisulfite conversion of DNA [11]. Although bi-
sulfite treatment can cause extensive degradation to DNA,
a few studies have already demonstrated the successful use
of DNA extracted from dried blood spots as well as ar-
chived tissue specimens for PCR-based loci-specific detec-
tion of methylation [12-14]. Furthermore, Beyan and
colleagues recently reported a successful use of dried blood
spot DNA for genome-wide DNA methylation detections
[15]. However, a systemic comparison between Guthrie
DNA and their matched frozen counterpart still remains to
be addressed.
In this study, we tested the feasibility of using DNA
extracted from dried blood spots for genome-wide
methylation profile assessment on the HM450 platform.
DNA from five individuals was extracted from three year
old archived dried blood spots, bisulfite converted and
hybridised onto the HM450 platform. The results from
this processing regimen were compared with those de-
rived from DNA extracted from matched frozen buffy
coat samples. The quality of data, reproducibility, and
correlation between the two sample types were assessed.
Results and discussion
Although dried blood spots provide a valuable bioresource
for research, DNA from this source has been shown to de-
teriorate with prolonged storage [16]. The potential use of
DNA from dried blood spots for genome-wide epigenetic
applications has, thus, remained speculative. Here, we
have successfully demonstrated the utility of dried blood
spot DNA for measuring genome-wide DNA methylation
using the Infinium HM450 BeadChip platform. We have
also compared these methylation measurements against
those of matched DNA extracted from buffy coats from
the same individuals (bled at the same time) to investigate
the commonality of methylation profiles as influenced by
the method of sample storage.
Quality of the samples and reproducibility of the platform
No sample analysed exceeded a mean detection p-value of
0.0017 across all probes (Figure 1 and Additional file 1:
Table S1). The majority of all individual probes (> 99.8%)
for each sample met the commonly accepted quality con-
trol detection p-value of 0.01, indicating high quality data
were obtained from both sample groups, but the analysis
of blood spot DNA generally showed slightly higher mean
detection p-values than buffy coat DNA, with fewer
probes having a detection p-value below the conventional
level of 0.01 (Figure 1). Wilcoxon signed rank test on
mean detection p-values revealed significantly higherquality data were obtained from buffy coat DNA than
from dried blood spot DNA (p-value = 0.03). This could
potentially be due to the poorer quality of DNA obtained
from blood spots. After removing probes with higher de-
tection p-values of 0.01 and probes on the X and Y chro-
mosomes, a total of 468,610 analysable probes, common
across 12 samples, remained for subsequent analyses.
Strong correlations, which is calculated across all probes
(r = 0.9961 and 0.9987, Figure 2 and Additional file 2:
Figure S1) were observed for β values between 2 pairs of
technical replicates, indicating the platform’s highly repro-
ducible data from both dried blood spots and frozen buffy
coat DNA, respectively.Consistency of DNA methylation between dried blood
spot and buffy coat DNA
DNA methylation profiles were compared between dried
blood spots and frozen buffy coats collected from the
same individuals. Unsupervised clustering analysis of the
most variable 101,691 probes (coefficient of variance > 0.2)
revealed strong similarities between the two sample types
within each individual. DNA methylation differences be-
tween individuals were apparent and sufficient to discrim-
inate matched pairs from unrelated samples (Figure 3).
When this was repeated on the entire probe set, a similar
pattern was detected, where most matched pairs closely
clustered (Additional file 2: Figure S1). These effects were
also reflected in the Pearson’s correlations (Additional file
2: Figure S2). The means correlation across all probes was
higher between technical replicates (r = 0.9932) when
compared with matching dried blood spot and buffy coat
samples (0.9907). The means correlation was lowest be-
tween unrelated individuals (0.9873). These findings sug-
gest that DNA from dried blood spots could be used as a
representative alternative to that derived from buffy coats
for genome-wide DNA methylation profiling.
Although dried blood spots and buffy coats displayed
considerably concordant DNA methylation profiles, their
correlation scores were slightly lower than for the tech-
nical replicates. Given this, we further investigated the
consistency of these discordant probes between the two
groups. The F-test was performed on the full dataset
which revealed a subset of 5,723 probes with q-values
(adjusted p-values) of 0.01 or less (Additional file 1:
Table S2). The number of Differentially Methylated
Probes (DMPs) might be fractional to the full set
of > 470,000 probes but it is possible that there is a small
but consistent change in methylation signature due to
differences in preparation methods and/or storage con-
ditions between the two sample types. We also cannot
rule out the possibility of the differences in cell popula-
tion between buffy coat and blood spot samples (i.e.
whole blood).
Figure 1 Mean Detection p-value for each sample is plotted against Number of Detectable CpGs with less than 0.01 Detection p-value.
Dried blood spot samples (GC) are in red and buffy coat samples (BC) are in black.
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firmed highly consistent patterns between the two
groups (Additional file 1: Figure S3). These probes were
located at almost identical spots on the scatterplots for
different individuals. Interestingly, the majority of these
probes was apparently hypermethylated for both groups
but was slightly less methylated for dried blood spots.
Nevertheless, the discordance in β values of these probes
generally did not exceed the platform’s commonly
accepted sensitivity of 0.2 β values (Additional file 1:
Figure S4) [10]. These probes were neither discordant
between technical replicates, nor in the same sample
types between unrelated individuals (Additional file 2:
Figure S5). Processing the data using other normalisa-
tion methods (e.g. ssn, quantile), transformed the data
significantly but the large proportion of these probes
was still present (data not shown).
It is possible that these DMPs represent technical arte-
facts arising from the method of sample storage. Of the
5,723 probes, 1,516 were not associated with any gene,
while the rest were associated with 3,370 different genes.
The greatest proportion of these DMPs was located withina gene body, not associated with a CpG island, and
were Infinium Type II design probes (Additional file 1:
Table S3). A proportion (1,006) of these probes also over-
lapped a SNP (Additional file 1: Table S2) and some
probes covered more than one CpG dinucleotide. Many of
these covariates on the HM450 platform can potentially
influence hybridisation efficiency, thus influencing the
resulting measurements, and are the topic of ongoing dis-
cussion [9,17]. Further studies are required to address
such potential technical artefacts.
Conclusion
In summary, we have demonstrated the utility of DNA
extracted from archived dried blood spots for detecting
genome-wide DNA methylation profiles using the
Infinium HumanMethylation450 platform. Although
dried blood spot DNA can degrade, especially over
prolonged storage times/period [16], we were able to
obtain high quality data comparable to those obtained
from DNA derived from matched frozen buffy coats.
We also report that the majority of probes showed
highly comparable methylation patterns within matched
Figure 2 β-value Density Plots. A-B, Density plots for dried blood spot technical replicates and buffy coats technical replicates. C–G, density
plots for matched samples (dried blood spot (GC) versus buffy coat (BC)) for each of the five individuals.
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suitable for these types of analyses. Furthermore, al-
though we used DNA isolated from twenty 3.2 mm
dried blood spot punches in this study, this could poten-
tially be reduced to a few punches where starting mater-
ial is limited. Our findings will greatly increase the
scope of biological resources suitable for Epigenome
Wide Association Studies (EWAS) [18,19].Figure 3 Unsupervised clustering plot based on the
methylation (M) values of the number of variable genes.
Samples from the same individual (GC, dried blood spot; BC, buffy
coat) are labelled with the same number. Duplicates from individual
1 are labelled with _T2. The clustering analysis was performed on
the top 101,691 most variable probes (CV > 0.2). The variable probes
were selected by calculating the Coefficient of Variance (CV,
standard deviation/mean).Methods
DNA purification from buffy coats and dried blood spots
Three year old-archived dried blood spots and matching
frozen buffy coats from five individuals were selec-
ted from the Melbourne Collaborative Cohort Study
biorepository [3] (Additional file 1: Table S1). At the
time of collection, blood spots and buffy coat samples
were simultaneously prepared. Dried blood spots were
prepared in custom printed Diagnostic Cellulose filter
paper (Whatman, Kent, United Kingdom) and stored in
air-tight containers at room temperature and buffy coat
samples were stored at -80°C as cell pellets. A total of
12 matched samples, including one technical replicate
pair (same DNA hybridised onto different arrays on
same slide), were selected.
DNA extractions from buffy coats were performed
using Qiagen mini spin columns (Hilden, Germany)
while dried blood spot DNA was extracted using a
method developed in-house: Twenty 3.2 mm diameter
archived blood spot punches were added to 200 ul phos-
phate buffered saline and homogenised using the
TissueLyser (Qiagen), which enables a more complete
removal of blood materials from the filter paper. The
resulting supernatant was transferred to a clean 1.5 mltube and DNA extracted using Qiagen mini spin
columns according to the manufacturer’s protocol.
The quality and quantity of DNA was assessed using the
Quant-iT™ PicogreenW dsDNA assay measured on the
QubitW Fluorometer (Life Technologies, Grand Island,
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Methylation-Gold kit, Zymo Research, Irvine, CA), quality
control analyses and the Infinium HM450 DNA methyla-
tion assays were performed at the Australian Genome Re-
search Facility as per the manufacturers’ instructions.
Illumina Infinium HumanMethylation450: data processing
Data were imported to an R environment and assessed
using the minfi package version 1.2.0 (www.bioconductor.
org) [20]. The overall data quality for individual samples
was examined by calculating mean detection p-values.
The raw colour channels were corrected using the internal
control probes and converted into methylation levels.
Subset-quantile Within Array Normalisation (SWAN)
normalisation was performed to correct for technical dis-
crepancies between Type I and Type II [21]. Probes with
detection P-values above 0.01 were considered to be tech-
nical noise and excluded from further analysis. Probes on
X and Y chromosomes were removed to eliminate any dif-
ferences attributable to the “sex chromosomes” [9].
M-values and absolute methylation (β) values were cal-
culated using minfi. Statistical tests were performed
using M-values. Unsupervised clustering plots were
generated using the lumi R package and the variable
probes were selected according to coefficient of vari-
ance, which is calculated by standard deviation divided
by mean across individuals [22]. DMPs were identified
using an F-test in minfi.
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available in supplementary tables. The dataset will be
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Additional files
Additional file 1: Table S1. Table of samples used in the study. 1 GC
denotes Guthrie Card (Dried blood spot) DNA and BC denotes Buffy Coat
DNA. 2 Mean Detection p-value of all probes for each sample. Table S2.
List of DMPs between dried blood spot samples and flash frozen buffycoat samples. Table S3. Probes Design type and genomic location of
5,723 differentially methylated probes. Table S4. NanoDrop
spectrophotometer 260/230 and 260/280 readings.
Additional file 2: Figure S1. Unsupervised clustering plot on the
methylation (M) values of the entire set of detected probes. Technical
replicates show the greatest similarities to each other. Samples extracted
from same individuals generally show close relationships. However,
individual 4 and 5 exhibit slightly higher similarities within sample types
than within individuals. Figure S2. Scatterplot matrix showing
relationships in DNA methylation (Beta values) between samples and
Pearson’s correlations between technical replicates (light shade), within
matched samples (dark shade) and between unrelated individual samples
(not shaded). The Pearson’s correlations were calculated across all
detected probes. Notably higher correlations were detected within
technical replicates and matched pairs than between unrelated
individuals. GC – Guthrie spot (dried blood spot) samples, BC – Buffy coat
samples. Figure S3. Scatterplots of matched dried blood spot and buffy
coat βvalues of individuals 1 to 5 (A to F). The differentially methylated
probes between dried blood spot and buffy coat groups were
highlighted in red. A, Scatterplot of Guthrie spot and buffy coat samples
from individual 1. B, Scatterplot of technical replicate Guthrie spot and
buffy coat samples from individual 1. C. Samples from individual 2, D,
Samples from individual 2. E, Samples from individual 4. F, Samples from
individual 5. Figure S4. Histograms Showing Mean Differences in DNA
methylation values (Δβ) with normal curves. A, Mean differences in
β-values (Δβ) between matched dried blood spot and buffy coats
samples (5 pairs). B, between technical replicates (2 pairs). Mean
differences between two sample groups were generally less than 0.1.
Figure S5 Scatterplots of technical replicates (A and B) and dried blood
spots (C)/buffy coats (D) of unrelated individuals. Red dots highlight
DMPs between two tissue types. Note the DMPs between sample groups
are highly correlative between technical replicates (A and B), same
sample types between unrelated individuals (C and D). X and y
axes – β values.
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